Search research articles
Contact Us
Filters
Showing results (51-60 of 94) with videos related to
Page
of 10
Sort By:
International Journal of Radiation Oncology, Biology, Physics
|
August 13, 2018
Phase 1 Study of Spinal Cord Constraint Relaxation With Single Session Spine Stereotactic Radiosurgery in the Primary Management of Patients With Inoperable, Previously Unirradiated Metastatic Epidural Spinal Cord Compression
Amol J Ghia, Nandita Guha-Thakurta, Kenneth Hess, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 23, 2004
Glutathione S-transferase polymorphisms and survival in primary malignant glioma
M Fatih Okcu, Mano Selvan, Li-E Wang, et al.
Scientific Reports
|
February 22, 2020
Phase I studies of vorinostat with ixazomib or pazopanib imply a role of antiangiogenesis-based therapy for TP53 mutant malignancies
Yudong Wang, Filip Janku, Sarina Piha-Paul, et al.
Oncotarget
|
September 22, 2018
Prevalence of MDM2 amplification and coalterations in 523 advanced cancer patients in the MD Anderson phase 1 clinic
Vikas Dembla, Neeta Somaiah, Pedro Barata, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 12, 2014
Positron emission tomography/computed tomography findings during therapy predict outcome in patients with diffuse large B-cell lymphoma treated with chemotherapy alone but not in those who receive consolidation radiation
Bouthaina S Dabaja, Kenneth Hess, Ferial Shihadeh, et al.
Practical Radiation Oncology
|
April 17, 2020
Costs and Complications After a Diagnosis of Prostate Cancer Treated With Time-Efficient Modalities: An Analysis of National Medicare Data
Chad Tang, Xiudong Lei, Grace L Smith, et al.
Journal of Neurosurgery
|
February 12, 2013
A prospective randomized trial of perioperative seizure prophylaxis in patients with intraparenchymal brain tumors
Adam S Wu, Victoria T Trinh, Dima Suki, et al.
Plos One
|
March 4, 2014
FBXW7 mutations in patients with advanced cancers: clinical and molecular characteristics and outcomes with mTOR inhibitors
Denis L Jardim, Jennifer J Wheler, Kenneth Hess, et al.
Neuro-Oncology
|
August 24, 2010
A phase I factorial design study of dose-dense temozolomide alone and in combination with thalidomide, isotretinoin, and/or celecoxib as postchemoradiation adjuvant therapy for newly diagnosed glioblastoma
Mark R Gilbert, Javier Gonzalez, Kathy Hunter, et al.
British Journal of Cancer
|
February 21, 2018
Development of a prognostic scoring system for patients with advanced cancer enrolled in immune checkpoint inhibitor phase 1 clinical trials
Shiraj Sen, Kenneth Hess, David S Hong, et al.
Page
of 10
Search research articles
Search
Showing results (51-60 of 94) with videos related to
Sort By:
Page
of 10
International Journal of Radiation Oncology, Biology, Physics
|
August 13, 2018
Phase 1 Study of Spinal Cord Constraint Relaxation With Single Session Spine Stereotactic Radiosurgery in the Primary Management of Patients With Inoperable, Previously Unirradiated Metastatic Epidural Spinal Cord Compression
Amol J Ghia, Nandita Guha-Thakurta, Kenneth Hess, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 23, 2004
Glutathione S-transferase polymorphisms and survival in primary malignant glioma
M Fatih Okcu, Mano Selvan, Li-E Wang, et al.
Scientific Reports
|
February 22, 2020
Phase I studies of vorinostat with ixazomib or pazopanib imply a role of antiangiogenesis-based therapy for TP53 mutant malignancies
Yudong Wang, Filip Janku, Sarina Piha-Paul, et al.
Oncotarget
|
September 22, 2018
Prevalence of MDM2 amplification and coalterations in 523 advanced cancer patients in the MD Anderson phase 1 clinic
Vikas Dembla, Neeta Somaiah, Pedro Barata, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 12, 2014
Positron emission tomography/computed tomography findings during therapy predict outcome in patients with diffuse large B-cell lymphoma treated with chemotherapy alone but not in those who receive consolidation radiation
Bouthaina S Dabaja, Kenneth Hess, Ferial Shihadeh, et al.
Practical Radiation Oncology
|
April 17, 2020
Costs and Complications After a Diagnosis of Prostate Cancer Treated With Time-Efficient Modalities: An Analysis of National Medicare Data
Chad Tang, Xiudong Lei, Grace L Smith, et al.
Journal of Neurosurgery
|
February 12, 2013
A prospective randomized trial of perioperative seizure prophylaxis in patients with intraparenchymal brain tumors
Adam S Wu, Victoria T Trinh, Dima Suki, et al.
Plos One
|
March 4, 2014
FBXW7 mutations in patients with advanced cancers: clinical and molecular characteristics and outcomes with mTOR inhibitors
Denis L Jardim, Jennifer J Wheler, Kenneth Hess, et al.
Neuro-Oncology
|
August 24, 2010
A phase I factorial design study of dose-dense temozolomide alone and in combination with thalidomide, isotretinoin, and/or celecoxib as postchemoradiation adjuvant therapy for newly diagnosed glioblastoma
Mark R Gilbert, Javier Gonzalez, Kathy Hunter, et al.
British Journal of Cancer
|
February 21, 2018
Development of a prognostic scoring system for patients with advanced cancer enrolled in immune checkpoint inhibitor phase 1 clinical trials
Shiraj Sen, Kenneth Hess, David S Hong, et al.
Page
of 10